ResearchAndMarkets.com released and added the 2025 Directory of Pharmaceutical Venture Capital & Private Equity Firms, a comprehensive, current directory for VC and PE investors in pharmaceuticals, biotechnology, and medical devices.

The directory has been integrated into ResearchAndMarkets.com’s offering and updated to reflect currency and new content.

Firms are listed alphabetically by name with offices shown by city, and the indexes include Company Names, Industry Preference, Executives, and Geographical locations.

The directory provides direct access to information on over 500 firms and thousands of partners, including detailed contact data, investment parameters, and fund information.

Additional information and access are available via the ResearchAndMarkets.com product page and a linked Business Wire press release.

Users can search for firms by industry and investment level, from $200,000 up to $50 million, and identify which VC firms funded specific companies.

The 2025 edition is extensively updated to offer current, detailed information for entrepreneurs and businesses worldwide.

The directory covers global regions—Europe, the Americas, Asia, the Middle East, and Africa—presenting a worldwide resource for researching the pharmaceutical investment community.

Each firm profile includes names, addresses, contact details, managing partners and backgrounds, satellite offices, mission statements, fund sizes, investment criteria and stages, industry and geographic preferences, and portfolio companies.

Industries covered span Pharmaceuticals, Biotechnology, Biopharmaceuticals, Drug Development, Clinical Research, Life Sciences, and Medical Technology.